Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.61 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates
 
Via Benzinga
Topics Stocks
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters
Metsera said that it would be entitled to terminate its merger agreement with Pfizer if Novo’s proposal continues to be superior. 
Via Stocktwits
Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs
Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID product sales. 
Via Benzinga
Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations
Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year... 
Via StockStory
Earnings Scheduled For November 4, 2025
 
Via Benzinga
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise
Via Stocktwits
Check Out What Whales Are Doing With PFE
 
Via Benzinga
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit
Via Stocktwits
Pfizer Raises Profit Outlook Even As Third-Quarter Sales Decline
Pfizer beat third-quarter expectations Tuesday, though both sales and profit fell year over year. The company also hiked its profit view. 
Via Investor's Business Daily
Is Eli Lilly a Millionaire Maker?
Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider. 
Via The Motley Fool
Topics Intellectual Property
Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops
Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance... 
Via StockStory
Pfizer Inc (NYSE:PFE) Reports Q3 2025 Earnings Beat and Raises Full-Year Profit Guidance
Pfizer Q3 2025 earnings beat estimates and the company raised its full-year profit guidance, highlighting strong cost management and non-COVID portfolio growth. 
Via Chartmill
Topics Earnings
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
Pfizer Tops EPS Expectations In Q3 2025 Despite Revenue Decline
Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year EPS guidance raise. 
Via Talk Markets
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies. 
Via The Motley Fool
Topics Energy Stocks
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
 
Via Benzinga
Uber, AMD And 3 Stocks To Watch Heading Into Tuesday
Stock futures trading lower, watch Uber, Upwork, AMD, Starbucks, Pfizer earnings. Starbucks forms China JV. Cramer advises against AT&T. 
Via Benzinga
Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts
Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, among others. 
Via Benzinga
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session.
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Tech Titans Unite and Consumer Giants Merge: Amazon-OpenAI Partnership and Kenvue Buyout Ignite S&P 500 and Nasdaq Gains
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by... 
Via MarketMinute
Topics Artificial Intelligence Lawsuit Stocks
Did Novo Nordisk Just Say "Checkmate" to Pfizer?
These two leading drugmakers are fighting over a promising GLP-1 candidate. 
Via The Motley Fool
Topics Intellectual Property
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo
Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk. 
Via Investor's Business Daily
Topics Economy Lawsuit
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization. 
Via Benzinga
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle
Pfizer sues Metsera and Novo Nordisk, alleging breach of contract and antitrust violations over a rival $9 billion bid challenging its $4.9 billion merger deal. 
Via Benzinga
Topics Lawsuit
Insights Ahead: Pfizer's Quarterly Earnings
 
Via Benzinga
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon
The healthcare industry is chock-full of opportunities for long-term investors. 
Via The Motley Fool
Topics Government World Trade
How To Earn $500 A Month From Pfizer Stock Ahead Of Q3 Earnings
Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly. 
Via Benzinga
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. 
Via Benzinga
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
From Pfizer Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.